Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | SHBG | P04278 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14931538 | 1.00 | METAP1 (0.41) | METAP1CYP1A2SIGMAR1EPHX1SHBG | |
| SCHEMBL4449485 | 1.00 | METAP1 (0.41) | METAP1CYP1A2SIGMAR1EPHX1SHBG | |
| SCHEMBL21753846 | 0.95 | METAP1 (0.37) | METAP1CYP1A2SIGMAR1EPHX1SHBG | |
| SCHEMBL5707369 | 0.93 | METAP1 (0.34) | METAP1CYP1A2EPHX1SHBG | |
| SCHEMBL28405594 | 0.88 | METAP1 (0.31) | METAP1 | |
| SCHEMBL4675951 | 0.76 | EPHX1 (0.37) | CYP1A2EPHX1SHBGTP53 | |
| SCHEMBL2992784 | 0.76 | EPHX1 (0.48) | METAP1CYP1A2SIGMAR1EPHX1SHBG | |
| SCHEMBL2990994 | 0.76 | METAP1 (0.44) | METAP1CYP1A2SIGMAR1EPHX1SHBG | |
| SCHEMBL9213591 | 0.76 | EPHX1 (0.37) | EPHX1SHBGTP53 | |
| SCHEMBL6873952 | 0.76 | EPHX1 (0.37) | CYP1A2EPHX1SHBGTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020040094-A1 | POLYMER, COMPOSITION CONTAINING SAME, CURING METHOD THEREFOR, CURED PRODUCT THEREOF, AND POLYMER MANUFACTURING METHOD | 株式会社ADEKA | 2020-02-27 | — | — | WO | disclosed |